To include your compound in the COVID-19 Resource Center, submit it here.

VTP-27999: Phase I data

A placebo- and active-controlled Phase I trial in 24 healthy volunteers showed that all doses of once-daily VTP-27999 were well

Read the full 202 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE